IC-BASAROTs: New Practice Method for More Accurate Bed-side Assessment of Individual Energy Expenditure

April 9, 2018 updated by: Luzia Valentini, University of Applied Sciences Neubrandenburg

IC-BASAROTs: Verification of a New Practice Method for More Accurate Bed-side Assessment of Individual Energy Expenditure

Assessment of resting energy expenditure (REE) by indirect calorimetry (IC) in 1400 healthy individuals for arithmetical transformation into an bedside tool to estimate energy requirements in dietary practice (BASAROTs). A multinational, multicenter, prospective cross-sectional study.

Study Overview

Status

Unknown

Detailed Description

The assessment of energy expenditure is the basic requirement for any nutritional therapy. Nevertheless, there is still no accurate, scientifically validated and practical bedside tool.

The reference method for energy expenditure measurement is indirect calorimetry (IC). High costs, time requirements and the need for trained personal are main reasons for its limited use in clinical practice. Also arithmetical calculations, such as the Harris-Benedict equation, are not widely accepted.

In general energy expenditure is often estimated by so called rules of thumbs, a method requiring only one multiplication with body weight (for example: 25 kcal/kg body weight). Sex, age and BMI are usually not considered, although they are independent predictors of energy expenditure. Thus, energy expenditure estimations are often inaccurate, especially in older and overweight/obese persons.

Therefore, it is important to develop a bedside tool that is more accurate but simple enough to be accepted by practitioners. In 2004, the Austrian Society of Clinical Nutrition published the first BMI, aged and sex adapted rule of thumbs, called BASAROTs (BMI Age Sex Adjusted Rule Of Thumbs). Those were, however, based on results of the Harris Benedict equation.

The main objective of the present study is, therefore, to replace the existing BASAROTs by BASAROTs based on actual measurements of resting energy expenditure by indirect calorimetry (IC-BASAROTs).

Study Type

Observational

Enrollment (Anticipated)

1400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bavaria
      • Munich, Bavaria, Germany, 80992
    • Hesse
      • Fulda, Hesse, Germany, 36030
    • Mecklenburg-Western Pomerania
      • Neubrandenburg, Mecklenburg-Western Pomerania, Germany, 17033
        • Recruiting
        • Dietrich Bonheoffer Hospital of Neubrandenburg
        • Contact:
          • Peter Keil, Dr. med.
          • Phone Number: +49 0375 775 3700
          • Email: keiljp@dbknb.de
      • Neubrandenburg, Mecklenburg-Western Pomerania, Germany, 17033
        • Recruiting
        • University of Applied Sciences Neubrandenburg
        • Contact:
        • Contact:
    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Germany, 55116
    • Saxony
      • Leipzig, Saxony, Germany, 04103

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Minimum sample size of n = 1400: 700 mostly healthy people (50% women, aged 18-100 years, BMI 16.5 to 39.9 kg / m²), 420 underweight individuals (50% women, 18 years to 100 years, BMI from 14.0 to 16.4 kg/m²), 280 morbidly obese (50% women,18 years to 100 years, BMI 40.0-49,9 kg/m²).

Recruitment of volunteers is performed in the local trial centers.

Description

Inclusion Criteria:

  • female, male
  • 18 years to 85 years
  • Body Mass Index: 14,0 - 49,9 kg/m²
  • Eastern Cooperative Oncology Group (ECOG) Performance Status (Grade 0 or 1)
  • normal thyroid function
  • subjective health in dependence of BMI (underweight, normal weight, obesity, morbid obesity)

Exclusion Criteria:

  • implanted pacemaker
  • amputations
  • paresis (mono- and diparesis)
  • Asian or African descent
  • above-average physical activity (competitive sport)
  • present or suspicion of malignant neoplasms (tumors, metastases, hemato-oncological diseases)
  • severe diseases (organ diseases, neurological diseases)
  • severe dementia (MMSE < 20 points)
  • pregnancy
  • participation in other trials
  • subjects with expect non-compliance to protocol guidelines
  • intake of:
  • lithium compound
  • neuroleptics: Olanzapine (Zyprexa ®), Clozapine, Sertindole, Ziprasidone, Haloperidol, Thioridazine
  • anticonvulsant (Carbamazepin, Valproic Acid, Topiramate)
  • noradrenalin-reuptake-inhibitor (NARI): Reboxetine , Atomoxetine
  • tricyclic antidepressants (Amitryptiline, Clomipramine, Doxepin, Imipramine, Trimipramin)
  • Lorcaserin
  • interferon-alfa, interferon-beta
  • Baclofen
  • Orciprenaline
  • Amiodarona
  • Insulin
  • corticoid therapy (oral)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Female, BMI: 14,00-16,49 kg/m²
Age: 18 - 100 Years
Female, BMI: 16,50-18,49 kg/m²
Age: 18 - 100 years
Female, BMI: 18,50-19,99 kg/m²
Age: 18 - 100 years
Female, BMI: 20,00-24,99 kg/m²
Age: 18 - 100 years
Female, BMI: 25,00-29,99 kg/m²
Age: 18 - 100 years
Female, BMI: 30,00-34,99 kg/m²
Age: 18 - 100 years
Female, BMI: 35,00-39,99 kg/m²
Age: 18 - 100 years
Female, BMI: 40,00-44,99 kg/m²
Age: 18 - 100 years
Female, BMI: 45,00-49,99 kg/m²
Age: 18 - 100 years
Male, BMI: 14,00-16,49 kg/m²
Age: 18 - 100 years
Male, BMI: 16,50-18,49 kg/m²
Age: 18 - 100 years
Male, BMI: 18,50-19,99 kg/m²
Age: 18 - 100 years
Male, BMI: 20,00-24,99 kg/m²
Age: 18 - 100 years
Male, BMI: 25,00-29,99 kg/m²
Age: 18 - 100 years
Male, BMI: 30,00-34,99 kg/m²
Age: 18 - 100 years
Male, BMI: 35,00-39,99 kg/m²
Age: 18 - 100 years
Male, BMI: 40,00-44,99 kg/m²
Age: 18 - 100 years
Male, BMI: 45,00-49,99 kg/m²
Age: 18 - 100 years

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
resting energy expenditure (REE) (kcal)
Time Frame: 15 minutes
Assessed by indirect calorimetry
15 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood pressure (mm Hg)
Time Frame: one single (baseline) measurement under standardized conditions
upper arm measurement by certified medical device
one single (baseline) measurement under standardized conditions
Body temperature (°C)
Time Frame: one single (baseline) measurement under standardized conditions
measured axillar, by infra-red ear thermometer and non-contact thermoscan
one single (baseline) measurement under standardized conditions
Heart rate (bpm)
Time Frame: one single (baseline) measurement under standardized conditions
measured by heart rate band and blood pressure device
one single (baseline) measurement under standardized conditions
Body weight (kg)
Time Frame: one single (baseline) measurement under standardized conditions
measured by electronic scale integrated in BIA device
one single (baseline) measurement under standardized conditions
Body height (m)
Time Frame: one single (baseline) measurement under standardized conditions
measured by digital stationary stadiometer
one single (baseline) measurement under standardized conditions
Fat mass (FM) (kg)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance analysis (BIA)
one single (baseline) measurement under standardized conditions
Fat-free mass (FFM) (kg)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Fat-free mass index (FFMI) (kg/m²)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Fat mass index (FMI) (kg/m²)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Skeletal muscle mass (SMM) (kg)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Total body water (TBW) (l)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Extracellular water (ECW) (l)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Resistance (R) (Ω)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Reactance (Xc) (Ω)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Phase angle (°)
Time Frame: one single (baseline) measurement under standardized conditions
measured by bioelectrical impedance Analysis (BIA)
one single (baseline) measurement under standardized conditions
Waist circumference (cm)
Time Frame: one single (baseline) measurement under standardized conditions
measured by measuring tape
one single (baseline) measurement under standardized conditions
International Physical Activity Questionnaire (IPAQ) short form
Time Frame: one single (baseline) interview
one single (baseline) interview

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Luzia Valentini, Prof. Dr., Neubrandenburg University of Applied Sciences

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2015

Primary Completion (ANTICIPATED)

December 1, 2019

Study Completion (ANTICIPATED)

December 1, 2020

Study Registration Dates

First Submitted

February 8, 2016

First Submitted That Met QC Criteria

February 12, 2016

First Posted (ESTIMATE)

February 15, 2016

Study Record Updates

Last Update Posted (ACTUAL)

April 11, 2018

Last Update Submitted That Met QC Criteria

April 9, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BB023/15

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The other study centers forward us pseudonymised participant data for evaluation. It might also be possible that we share selected pseudonymised participant data with the other study centers.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Subscribe